Parkinson's disease ▲ Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)








Last Updated: Apr 28, 2016

• Parkinson's disease: Guilt by genetic association.
  by Asa Abeliovich & Herve Rhinn, Nature News, April 20, 2016
• Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease.
  Mo Ming-Shu, et al. Chinese medical journal 0 0 (9) 1053-1058
• Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
  Benitez Bruno A, et al. Molecular neurodegeneration 2016 0 (1) 29
• ?-synuclein genetic variability: A biomarker for dementia in Parkinson's disease.
  Guella Ilaria, et al. Annals of neurology 2016 4
• Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
  Marras Connie, et al. Movement disorders : official journal of the Movement Disorder Society 2016 4
• The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients.
  Fan Kuan, et al. Neuroscience letters 2016 4 133-136
• MC1R variants in Chinese Han patients with sporadic Parkinson's disease.
  Shi Chang-He, et al. Neurobiology of aging 2016 3
• Glutathione S-transferase M1 polymorphisms and Parkinson's disease risk: a meta-analysis.
  Wang Dan, et al. Neurological research 2016 3 1-7
• Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
  Kraemmer Julia, et al. Journal of neurology, neurosurgery, and psychiatry 2016 4
• APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
  Paul Kimberly C, et al. Journal of Parkinson's disease 2016 4
• Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.
  Vilas Dolores, et al. Movement disorders : official journal of the Movement Disorder Society 2016 4
• Genetic analysis of FGF20 variants in Chinese Han patients with essential tremor.
  Yuan Lamei, et al. Neuroscience letters 2016 3
• Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.
  Pont-Sunyer Claustre et al. Movement disorders : official journal of the Movement Disorder Society 2015 Jun 30(7) 904-8
• Possible association of CCDC62 rs12817488 polymorphism and Parkinson's disease risk in Chinese population: a meta-analysis.
  Lu Yanjun, et al. Scientific reports 2016 0 23991
• Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease.
  Altmann Vivian, et al. Pharmacogenomics 2016 3
• Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.
  Mok Kin Y, et al. The Lancet. Neurology 2016 3
• Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.
  Nixon-Abell Jonathon, et al. Frontiers in molecular neuroscience 2016 0 18
• Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.
  Oczkowska Anna, et al. Current genomics 2015 8 (4) 215-23
• Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
  van der Merwe Celia, et al. Neuroscience letters 2016 3 168-171
• Poly (ADP-ribose) polymerase-1 (PARP-1) -410C/T polymorphism in Sicilian patients with Parkinson's disease.
  Salluzzo Maria Grazia, et al. Journal of the neurological sciences 2016 4 95-6
• Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
  Williams-Gray Caroline H, et al. Movement disorders : official journal of the Movement Disorder Society 2016 3
• Structure, function and disease relevance of Omega-class glutathione transferases.
  Board Philip G, et al. Archives of toxicology 2016 3
• Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.
  Nicoletti Alessandra, et al. Journal of neurology 2016 3
• Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.
  Sesar Angel, et al. Journal of the neurological sciences 2016 3 321-5
• PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
  Miyake Yoshihiro, et al. Journal of the neurological sciences 2016 3 47-52
• Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole.
  MacDonald Hayley J, et al. Journal of cognitive neuroscience 2016 3 1-11
• RIT2 Polymorphisms: Is There a Differential Association?
  Emamalizadeh Babak, et al. Molecular neurobiology 2016 3
• Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity.
  Shu Yang, et al. PloS one 2016 0 (3) e0149739
• Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
  Dzamko Nicolas, et al. Movement disorders : official journal of the Movement Disorder Society 2016 2
• Chemokine gene variants in schizophrenia.
  Dasdemir Selcuk, et al. Nordic journal of psychiatry 2016 2 1-6

• CDC Information (0)
• CDC-Authored Pub (2)

• Human (0)
• Pathogen (2)

• Human (1694)
• Pathogen (0)

• Human (8)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB